https://www.merck.com/news/merck-receives-complete-response-letter-for-investigational-medicine-sugammadex-sodium-injection/
Merck Receives Complete Response Letter for Investigational Medicine Sugammadex Sodium Injection -...
Mar 22, 2023 - Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the company has received a Complete Response Letter from the U.S....
complete response lettersugammadex sodiummerckreceives
https://www.ebi.ac.uk/chebi/CHEBI:90952
sugammadex sodium (CHEBI:90952)
An organic sodium salt that is the octasodium salt of sugammadex. Used for reversal of neuromuscular blockade induced by rocuronium and vecuronium in adults...
sugammadex sodiumchebi